Krsnaa Diagnostics rises 4% after announcing plans to launch 600 new centers
The company will strengthen its footprint across Maharashtra, Himachal Pradesh, Punjab, West Bengal, and Rajasthan, with the spread across metropolitan, tier 2 and tier 3 cities, the company said in a BSE filing.

The company will strengthen its footprint across Maharashtra, Himachal Pradesh, Punjab, West Bengal, and Rajasthan, with the spread across metropolitan, tier 2 and tier 3 cities, the company said in a BSE filing.
The centers will be equipped to offer specialized services in precision medicine, genetics, genomics, and molecular diagnostics, along with the routine investigations of biochemistry and serology, which are commonly used in routine diagnostics tests, it added.
The centers will offer dedicated services for women’s health (hormones/ PCOD), diabetes monitoring, cardiac health, and cancer care, the filing said.
At 10:04 am, the scrip was trading 2 per cent higher at Rs 499 over its last day’s trading price of Rs 488 apiece. The stock has risen over 2 per cent in the last six months, while it has fallen nearly 33 per cent year-to-date.
Download ET Markets APP